New FDA commissioner wants to lower drug prices by increasing competition

The man in charge of keeping President Trump’s promise to make prescription drugs cheaper is the new head of the Food and Drug Administration, Dr. Scott Gottlieb.

Gottlieb said the solution is really as simple as supply and demand: More drugs on the market means more competition and, thus, lower prices.

Of course brand name medication manufacturers don’t want to share their secret formulas with generic competitors. And even once generics are developed, it can take up to four years to get them approved.

In his first exclusive sit-down camera interview with Fox News, Gottlieb said he wants to change things up.


“If we’re able to get generic competition onto the market sooner for certain drugs right now that don’t face generic competition, there’s no question that’s going to affect drug prices and overall drug spending,” Gottlieb said, adding that the results would “lower the overall cost burden on consumers and give consumers low-cost options.”

Gottlieb wants to cut the time from lab to pharmacy down to 8 to 10 months, with no tradeoff between speed and safety.

“I don’t think, if we’re making the products faster, that somehow it’s sacrificing our safety,” he said. “I think this is the way to make the process more efficient, get drugs to the market more quickly and also actually increase our ability to learn about the safety and effectiveness of those products.”


While acknowledging that new systems of payment and coverage for innovative treatments will be necessary, the FDA commissioner was very hopeful and excited about some of the new approaches that are in the early stages of…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *